Orofacial pain in cancer: Part II-clinical perspectives and management

Journal of Dental Research

Volumn 86, Issue 6, 2007, Pages 506-518

  Epstein, J B ^a   Elad, S ^b   Eliav, E ^c   Jurevic, R ^a   Benoliel, R ^b  

^a Department of Oral Medicine and Diagnostic Sciences   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Management; Orofacial pain in cancer; Quality of life

Indexed keywords

ADJUVANT THERAPY; FACE PAIN; HEAD AND NECK TUMOR; HUMAN; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; REVIEW;

FACIAL PAIN; HEAD AND NECK NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; PARANEOPLASTIC SYNDROMES;

EID: 34347218594     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600605     Document Type: Review

References (203)

1. Abraham PJ, Capobianco DJ, Cheshire WP (2003). Facial pain as the presenting symptom of lung carcinoma with normal chest radiograph. Headache 43:499-504.
2. Amato AA, Collins MP (1998). Neuropathies associated with malignancy. Semin Neurol 18:125-144.
3. Anderson CC, Ogle RG (1974). Facial pain of intracranial origin. Oral Surg Oral Med Oral Pathol 37:841-845.
4. Anderson NE, Cunningham JM, Posner JB (1987). Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol 3:245-299.
5. Antoine JC, Mosnier JF, Absi L, Convers P, Honnorat J, Michel D (1999). Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neural Neurosurg Psychiatry 67:7-14.
6. Ashby MA, Martin P, Jackson KA (1999). Opioid substitution to reduce adverse effects in cancer pain management. Med J Aust 170:68-71.
7. Barnouin J, Verdura Barrios T, Chassagne M, Ferez Cristia R, Arnaud J, Fleites Mestre P, et al. (2001). Nutritional and food protection against epidemic emerging neuropathy. Epidemiological findings in the unique disease-free urban area of Cuba. Int J Vitam Nutr Res 71:274-285.
8. Barrett AP (1986). Leukemic cell infiltration of the gingivae. J Periodonlol 57:579-581.
9. Beckmann UK, Hoppe F, Pfreundner L, Flentje MP (2005). Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck 27:36-43.
10. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000). Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33-39.
11. Benedetti C, Brock C, Cleeland C, Coyle N, Dube JE, Ferrell B, et al. (2000). NCCN practice guidelines for cancer pain. Oncology (Williston Park) 14(11A):135-150.
12. Bennett JH, Thomas G, Evans AW, Speight PM (2000). Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:323-332.
13. Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S (2007). Orofacial pain in cancer: part I-mechanisms. J Dent Res 86:xxx-xxx.
14. Berger A, Henderson M, Nadoolman W, Duffy V, Cooper D, Saberski L, et al. (1995). Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy. J Pain Symptom Manage 10:243-248.
15. Bergmann OJ, Andersen PL (1990). Acute oral candidiasis during febrile episodes in immunocompromised patients with haematologic malignancies. Scand J Infect Dis 22:353-358.
16. Bergmann OJ, Mogensen SC, Ellegaard J ( 1990). Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Inject Dis 9:184-190.
17. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. (2004). Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952.
18. Bindoff LA, Heseltine D (1988). Unilateral facial pain in patients with lung cancer: a referred pain via the vagus? Lancet 1(8589):812-815.
19. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biorklund A, et al. (2001). A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 111:1440-1452.
20. Bongers KM, Willigers HM, Koehler PJ (1992). Referred facial pain from lung carcinoma. Neurology 42:1841-1842.
21. Borbasi S, Cameron K, Quested B, Olver I, To B, Evans D (2002). More than a sore mouth: patients' experience of oral mucositis. Oncol Nurs Forum 29:1051-1057.
22. Borgmann A, Emminger W, Emminger-Schmidmeier W, Peters C, Gatterer- Menz I, Henze G, et al. (1994). Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients. Klin Padiatr 206:299-302.
23. Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994). Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30(B)(2):93-97.
24. Bubley GJ, Chapman B, Chapman SK, Crumpacker CS, Schnipper LE (1989). Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions. Antimicrob Agents Chemother 33:862-865.
25. Buchali A, Feyer P, Groll J, Massenkeil G, Arnold R, Budach V (2000). Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol 54:157-162.
26. Bullitt E, Tew JM, Boyd J (1986). Intracranial tumors in patients with facial pain. J Neurosurg 64:865-871.
27. Capobianco DJ (1995). Facial pain as a symptom of nonmetastatic lung cancer. Headache 35:581-585.
28. Caraceni A, Portenoy RK (1999). An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82:263-274.
29. Cerchietti LC, Navigante AH, Bonomi MR, Zaderajko MA, Menendez PR, Pogany CE, et al. (2002). Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 95:2230-2236.
30. Chalk CH, Windebank AJ, Kimmel DW, McManis PG (1992). The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neural Sci 19:346-351.
31. Chapman CR, Hill HF (1989). Prolonged morphine self-administration and addiction liability. Evaluation of two theories in a bone marrow transplant unit. Cancer 63:1636-1644.
32. Chapman CR, Donaldson GW, Jacobson RC, Hautman B (1997). Differences among patients in opioid self-administration during bone marrow transplantation. Pain 71:213-223.
33. Chaudhry V, Chaudhry M, Crawford TO, Simmons-O'Brien E, Griffin JW (2003). Toxic neuropathy in patients with pre-existing neuropathy. Neurology 60:337-340.
34. Cheng TM, Cascino TL, Onofrio BM (1993). Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 43:2298-2302.
35. Chow HT, Teh LY (2000). Sensory impairment after resection of the mandible: a case report of 10 cases. J Oral Maxillofac Surg 58:629-635.
36. Christiaans MH, Kelder JC, Arnoldus EP, Tijssen CC (2002). Prediction of intracranial metastases in cancer patients with headache. Cancer 94:2063-2068.
37. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. (1994). Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592-596.
38. Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD (1997). Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 72:333-346.
39. Cohen HV, Rosenheck AH (1998). Metastatic cancer presenting as TMD. A case report. J NJ Dent Assoc 69(3): 17-19.
40. Coleman RE (1997). Skeletal complications of malignancy. Cancer 80(8 Suppl): 1588-1594.
41. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, et al. (2001). Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 91(1-2): 123-130.
42. Contreras RJ, Beckstead RM, Norgren R (1982). The central projections of the trigeminal, facial, glossopharyngeal and vagus nerves: an autoradiographic study in the rat. J Auton Nerv Syst 6:303-322.
43. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. (2004). Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944.
44. Cuffari L, Tesseroli de Siqueira JT, Nemr K, Rapaport A (2006). Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:56-61.
45. D'Silva NJ, Summerlin DJ, Cordell KG, Abdelsayed RA, Tomich CE, Hanks CT, et al (2006). Metastatic tumors in the jaws: a retrospective study of 114 cases. J Am Dent Assoc 137:1667-1672.
46. Daggett P, Nabarro J (1984). Neurological aspects of insulinomas. Postgrad Med J 60(707):577-581.
47. de Wit R, van Dam F, Loonstra S, Zandbelt L, van Buuren A, van der Heijden K, et al. (2001). The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain. Pain 91:339-349.
48. del Campo JM, Felip E, Giralt J, Raspall G, Bescos S, Casado S, et al. (1997). Preoperative simultaneous chemoradiotherapy in locally advanced cancer of the oral cavity and oropharynx. Am J Clin Oncol 20:97-100.
49. Delfino JJ, Wilson TK, Rainero DM (1982). Metastatic adenocarcinoma from the colon to the mandible. J Oral Maxillofac Surg 40:188-190.
50. Des Prez RD, Freemon FR (1983). Facial pain associated with lung cancer: a case report. Headache 23:43-44.
51. Devulder J, Lambert J, Naeyaert JM (2001). Gabapentin for pain control in cancer patients' wound dressing care. J Pain Symptom Manage 22:622-626.
52. Dignani MC, Mykietiuk A, Michelet M, Intile D, Mammana L, Desmery P, et al. (2002). Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation. Bone Marrow Transplant 29:263-267.
53. Dodd MJ, Dibble SL, Miaskowski C, MacPhail L, Greenspan D, Paul SM, et al. (2000). Randomized clinical trial of the effectiveness of 3commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:39-47.
54. Dodd MJ, Dibble S, Miaskowski C, Paul S, Cho M, MacPhail L, et al. (2001). A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapyinduced oral mucositis. J Pain Symptom Manage 21:498-505.
55. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H, Quality Standards Subcommittee of the American Academy of Neurology (2004). Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63:959-965.
56. Dunbar PJ, Buckley P, Gavrin JR, Sanders JE, Chapman CR (1995). Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant. J Pain Symptom Manage 10:604-611.
57. Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, et al. (2005). Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27:421-428.
58. Durie BG, Katz M, Crowley J (2005). Osteonecrosis of the jaw and bisphosphonates. N Engl J Med353:99-102; discussion, 99-102.
59. Eisbruch A, Ship JA, Kim HM, Ten Haken RK (2001). Partial irradiation of the parotid gland. Semin Radiat Oncol 11:234-239.
60. Eisenberg E, Berkey CS, Carr DB, Mosteller F, Chalmers TC (1994). Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 12:2756-2765.
61. Eisenberg E, Marinangeli F, Birkhahn J, Paladini A, Varrassi G (2005). Time to modify the WHO Analgesic Ladder? Pain Clinical Updates 13(5): 1-4.
62. Elad S, Cohen G, Zylber-Katz E, Findler M, Galili D, Garfunkel AA, et al. (1999a). Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients. J Oral Pathol Med 28:170-172.
63. Elad S, Garfunkel AA, Enk CD, Galili D, Or R (1999b). Ultraviolet B irradiation: a new therapeutic concept for the management of oral manifestations of graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:444-450.
64. Elad S, Or R, Garfunkel AA, Shapira MY (2003). Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:308-311.
65. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003). The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531-1539.
66. Elting LS, Cooksley C, Garden AS (2005). Economic burden of radiotherapy-induced oral mucositis among patients with head and neck cancers (abstract). Support Care Cancer 13:443 (#15-097).
67. Enting RH, Oldenmenger WH, van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, et al. (2002). A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer 94:3049-3056.
68. Epstein JB (1997). Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients (discussion). J Oral Maxillofac Surg 55:454-455.
69. Epstein JB, Jones CK (1993). Presenting signs and symptoms of nasopharyngeal carcinoma. Oral Surg Oral Med Oral Pathol 75:32-36.
70. Epstein JB, Polsky B (1998). Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies. Clin Ther 20:40-57.
71. Epstein JB, Schubert MM (1993). Management of orofacial pain in cancer patients. Eur J Cancer B Oral Oncol 29(B)(4):243-250.
72. Epstein JB, Schubert MM (2003). Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Williston Park) 17:1767-1779; discussion, 1779-1782, 1791- 1792.
73. Epstein JB, Stewart KH (1993). Radiation therapy and pain in patients with head and neck cancer. Eur J Cancer B Oral Oncol 29(B)(3): 191-199.
74. Epstein JB, Wong FL (1994). The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int J Radiat Oncol Biol Phys 28:693-698.
75. Epstein JB, Wong FL, Stevenson-Moore P (1987). Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg 45:104-110.
76. Epstein JB, Stevenson-Moore P, Jackson S, Mohamed JH, Spinelli JJ (1989). Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 16:1571-1575.
77. Epstein JB, Sherlock C, Page JL, Spinelli J, Phillips G (1990). Clinical study of herpes simplex virus infection in leukemia. Oral Surg Oral Med Oral Pathol 70:38-43.
78. Epstein JB, Vickars L, Spinelli J, Reece D (1992). Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 73:682- 689.
79. Epstein J, Ransier A, Lunn R, Spinelli J (1994). Enhancing the effect of oral hygiene with the use of a foam brush with chlorhexidine. Oral Surg Oral Med Oral Pathol 77:242-247.
80. Epstein J, van der Meij E, McKenzie M, Wong F, Lepawsky M, Stevenson-Moore P (1997). Postradiation osteonecrosis of the mandible: a long-term follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83:657-662.
81. Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, et al. (1999). Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1-11.
82. Epstein JB, Epstein JD, Le ND, Gorsky M (2001a). Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:519-525.
83. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001b). Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389-398.
84. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. (2001e). Benzydamine HC1 for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 92:875-885.
85. Epstein JB, Truelove EL, Oien H, Allison C, Le ND, Epstein MS (2001d). Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol 37:632-637.
86. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002a). Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785-792.
87. Epstein JB, Tsang AH, Warkentin D, Ship JA (2002b). The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:39-44.
88. Eross EJ, Dodick DW, Swanson JW, Capobianco DJ (2003). A review of intractable facial pain secondary to underlying lung neoplasms. Cephalalgia23(1):2-5.
89. Fitzgibbon DR (2001). Cancer pain: management. In: Bonica's management of pain. Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Philadelphia: Lippincott Williams and Wilkins, pp. 658-703.
90. Fitzgibbon DR, Richard CR (2001). Cancer pain: assessment and diagnosis. In: Bonica's management of pain. Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Philadelphia: Lippincott Williams and Wilkins, pp. 623-658.
91. Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C (1998). The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 78:157-169.
92. Gallager FJ, Baxter DL, Denobile J, Taybos GM (1988). Glossodynia, iron deficiency anemia, and gastrointestinal malignancy. Report of a case. Oral Surg Oral Med Oral Pathol 65:130-133.
93. Gaston-Johansson F, Franco T, Zimmerman L (1992). Pain and psychological distress in patients undergoing autologous bone marrow transplantation. Oncol Nurs Forum 19:41-48.
94. Gellrich NC, Schramm A, Bockmann R, Kugler J (2002a). Follow-up in patients with oral cancer. J Oral Maxillofac Surg 60(4):380-386; discussion, 387-388.
95. Gellrich NC, Schimming R, Schramm A, Schmalohr D, Bremerich A, Kugler J (2002b). Pain, function, and psychologic outcome before, during, and after intraoral tumor resection. J Oral Maxillofac Surg 60(7):772-777.
96. Genot MT, Klastersky J (2005). Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. Curr Opin Oncol 17:236-240.
97. Goldberg HL (1997). Chest cancer refers pain to face and jaw: a case review. Cranio15:167-169.
98. Gorsky M, Epstein JB (1998a). Head and neck and intra-oral soft tissue sarcomas. Oral Oncol 34:292-296.
99. Gorsky M, Epstein JB (1998b). Melanoma arising from the mucosal surfaces of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:715-719.
100. Gwyn DG, Leslie RA, Hopkins DA (1985). Observations on the afferent and efferent organization of the vagus nerve and the innervation of the stomach in the squirrel monkey. J Comp Neural 239:163-175.
101. Hammerlid E, Taft C (2001). Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 84:149-156.
102. Hammerlid E, Silander E, Homestam L, Sullivan M (2001). Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head Neck 23:113-125.
103. Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, et al. (1997). Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 19:169-175.
104. Haya-Fernandez MC, Bagan JV, Murillo-Cortes J, Poveda-Roda R, Calabuig C (2004). The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis 10:346-348.
105. Hill HF, Mackie AM, Coda BA, Iverson K, Chapman CR (1991). Patient- controlled analgesic administration. A comparison of steady-state morphine infusions with bolus doses. Cancer 67:873-882.
106. Hirshberg A, Buchner A (1995). Metastatic tumours to the oral region. An overview. Eur J Cancer B Oral Oncol 31 (B)(6):355-360.
107. Hirshberg A, Leibovich P, Buchner A (1993). Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med 22:385-390.
108. Hirshberg A, Leibovich P, Buchner A (1994). Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med 23:337-341.
109. Huang HY, Wilkie DJ, Chapman CR, Ting LL (2003). Pain trajectory of Taiwanese with nasopharyngeal carcinoma over the course of radiation therapy. J Pain Symptom Manage 25:247-255.
110. Johnson AT, Maran AG (1982). Extra-cranial tumours of the infratemporal fossa. J Laryngol Otol 96:1017-1026.
111. Johnson R (2001). Herpes zoster - predicting and minimizing the impact of post-herpetic neuralgia. J Anlimicrob Chemother 47(Suppl T1): 1-8.
112. Jones AC, Freedman PD, Phelan JA, Baughman RA, Kerpel SM (1993). Cytomegalovirus infections of the oral cavity. A report of six cases and review of the literature. Oral Surg Oral Med Oral Pathol 75:76-85.
113. Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS (2006). Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer 14:505-515.
114. Joranson DE, Gilson AM (1998). Regulatory barriers to pain management. Semin Oncol Nurs 14:158-163.
115. Kanas RJ, Jensen JL, DeBoom GW (1987). Painful oral mucosal ulcers in a patient with small cell carcinoma of the lung. J Am Dent Assoc 115:75-76.
116. Kline RM, Meiman S, Tarantino MD, Herzig RH, Bertolone SJ Jr (1998). A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital. Bone Marrow Transplant 21:195-203.
117. Koka VN, Deo R, Lusinchi A, Roland J, Schwaab G (1990). Osteoradionecrosis of the mandible: study of 104 cases treated by hemimandibulectomy. J Laryngol Otol 104:305-307.
118. Komisar A, Silver C, Kainicki S (1985). Osteoradionecrosis of the maxilla and skull base. Laryngoscope 95:24-28.
119. Lema MJ (2002). Emerging options with coxib therapy. Cleve Clin J Med 69(Suppl 1):SI76-SI84.
120. Lipton A (1997). Bisphosphonates and breast carcinoma. Cancer 80(8 Suppl):l668-l673.
121. List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, et al. (1999). Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol17:1020-1028.
122. Littlewood T, Mandelli F (2002). The effects of anemia in hematologic malignancies: more than a symptom. Semin Oncol 29(3 Suppl 8):40-44.
123. Lossos A, Siegal T (1992). Numb chin syndrome in cancer patients: etiology, response to treatment, and prognostic significance. Neurology 42:1181-1184.
124. Lucas LK, Lipman AG (2002). Recent advances in pharmacotherapy for cancer pain management. Cancer Pract 10(Suppl 1):S14-S20.
125. Luyk NH, Hammond-Tooke G, Bishara SN, Ferguson MM (1991). Facial pain and muscle atrophy secondary to an intracranial tumour. Br J Oral Maxillofac Surg 29:204-207.
126. Magill L (2001). The use of music therapy to address the suffering in advanced cancer pain. J Palliat Care 17:167-172.
127. Mallecourt C, Delattre JY (2000). [Paraneoplastic neuropathies]. Presse Med 29:447-452 [article in French].
128. Mardinger O, Givol N, Talmi YP, Taicher S (2001). Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:445-451.
129. Marx RE (1983). Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41:283-288.
130. Marx RE (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115-1117.
131. Marx RE, Johnson RP (1987). Studies in the radiobiology of Osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 64:379-390.
132. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB (1993). Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 20:1493-1502.
133. McGuire DB, Yeager KA, Dudley WN, Peterson DE, Owen DC, Lin LS, et al. (1998). Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study. Cancer Nurs 21:385-393.
134. McKenzie MR, Wong FL, Epstein JB, Lepawsky M (1993). Hyperbaric oxygen and postradiation osteonecrosis of the mandible. Eur J Cancer B Oral Oncol 29(B)(3):201-207.
135. McNicol E, Strassels S, Goudas L, Lau J, Carr D (2004). Nonsteroidal antiinflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J Clin Oncol 22:1975-1992.
136. Menahem S, Shvartzman P (2004). High-dose fentanyl patch for cancer pain. J Am Board Fam Pract 17:388-390.
137. Menzies K., Murray J, Wilcock A (2000). Audit of cancer pain management in a cancer centre. Int J Palliat Nurs 6:443-447.
138. Mercadante S (1997). Malignant bone pain: pathophysiology and treatment. Pain 69:1-18.
139. Mercadante S, Fulfaro F, Casuccio A (2002). A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer 38:1358-1363.
140. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S (2001). Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93:247-257.
141. Modi BJ, Knab B, Feldman LE, Mundt AJ, Yao M, Pytynia KB, et al. (2005). Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 6:1143-1155.
142. Mohan S, Epstein JB (2003). Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol 39:537-546.
143. Monaghan AM, McKinlay KP (1991). An intracranial tumour causing dental pain. Br Dent J 171:249-250.
144. Mystakidou K, Befon S, Tsilika E, Dardoufas K, Georgaki S, Vlahos L (2002). Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids. Oncology 62:9-16.
145. Nestor JJ (1991). Unilateral facial pain in lung cancer. Lancet 338(8775): 1149.
146. Nestor JJ, Ngo LK (1994). Incidence of facial pain caused by lung cancer. Ololaryngol Head Neck Surg 111:155-156.
147. Neville-Webbe H, Coleman RE (2003). The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia. Palliat Med 17:539-553.
148. Oster G, Vera-Llonch M, Ford C, Lu J, Khazanov I, Sonis S (2005). Oral mucositis (OM) and outcomes of allogeneic (AL) hematopoietic stem cell transplantation (HSCT) (abstract). Support Care Cancer 13:447 (#15-107).
149. Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM (2000). Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage 20:374-387.
150. Paul T, Katiyar BC, Misra S, Pant GC (1978). Carcinomatous neuromuscular syndromes. A clinical and quantitative electrophysiological study. Brain 101:53-63.
151. Payne R, Coluzzi P, Hart L, Simmonds M, Lyss A, Rauck R, et al. (2001). Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage 22:575-583.
152. Pederson C, Parran L, Harbaugh B (2000). Children's perceptions of pain during 3 weeks of bone marrow transplant experience. J Pediatr Oncol Nurs 17:22-32.
153. Pillitteri LC, Clark RE (1998). Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 22:495-498.
154. Portenoy RK (1990). Pain and quality of life: clinical issues and implications for research. Oncology (Williston Park) 4:172-178; discussion, 194.
155. Portenoy RK, Lesage P (1999). Management of cancer pain. Lancet 353(9165): 1695-1700.
156. Puca A, Meglio M, Tamburrini G, Vari R (1993). Trigeminal involvement in intracranial tumours. Anatomical and clinical observations on 73 patients. Acta Neurochir (Wien) 125(1-4):47-51.
157. Puca A, Meglio M, Vari R, Tamburrini G, Tancredi A (1995). Evaluation of fifth nerve dysfunction in 136 patients with middle and posterior cranial fossae tumors. Eur Neural 35:33-37.
158. Reuther T, Schuster T, Mende U, Kubler A (2003). Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients - a report of a thirty year retrospective review. Inl J Oral Maxillofac Surg 32:289-295.
159. Ripamonti C, Dickerson ED (2001). Strategies for the treatment of cancer pain in the new millennium. Drugs 61:955-977.
160. Rogers SN, Lowe D, McNally D, Brown JS, Vaughan ED (2003). Health-related quality of life after maxillectomy: a comparison between prosthetic obturation and free flap. J Oral Maxillofac Surg 61:174-181.
161. Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002). Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs 25:461-467.
162. Rosier R (1992). Bone pain. Am J Hasp Palliat Care 9:37.
163. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. (2004). Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026-2046.
164. Ruggiero SL, Mehrotra B (2004). Ten years of alendronate treatment for osteoporosis in postmenopausal women. N Engl J Med 351:190-192; author reply, 190-192.
165. Ruoff G, Lema M (2003). Strategies in pain management: new and potential indications for COX-2 specific inhibitors. J Pain Symptom Manage 25(2Suppl):S21-S31.
166. Sabino MA, Luger NM, Mach DB, Rogers SD, Schwei MJ, Mantyh PW (2003). Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. Inl J Cancer 104:550-558.
167. Sanchez Aniceto G, Garcia Penin A, de la Mata Pages R, Montalvo Moreno JJ (1990). Tumors metastatic to the mandible: analysis of nine cases and review of the literature. J Oral Maxillofac Surg 48:246-251.
168. Sarlani E, Schwartz AH, Greenspan JD, Grace EG (2003). Facial pain as first manifestation of lung cancer: a case of lung cancer-related cluster headache and a review of the literature. J Orofac Pain 17:262-267.
169. Schafers M, Sommer C (2001). Polyneuropathies. In: Pain in peripheral nerve diseases. Sommer C, editor. Basel: Karger, pp. 53-108.
170. Schnetler J, Hopper C (1989). Intracranial tumours presenting with facial pain. Er Dent J 166:80-83.
171. Schoenen J, Broux R, Moonen G (1992). Unilateral facial pain as the first symptom of lung cancer: are there diagnostic clues? Cephalalgia 12:178-179.
172. Schreiber A, Kinney LA, Salman R (1991). Large-cell lymphoma of the infratemporal fossa presenting as myofacial pain. J Craniomandib Disord 5:286-289.
173. Schubert MM (1991). Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent 1:384-397.
174. Shaiova L, Lapin J, Manco LS, Shasha D, Hu K, Harrison L, et al. (2004). Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer 12:268-273.
175. Shakespeare TP, Stevens MJ (1996). Unilateral facial pain and lung cancer. Australas Radiol 40:45-46.
176. Sharav Y, Feinsod M (1977). Nasopharyngeal tumor initially manifested as myofascial pain dysfunction syndrome. Oral Surg Oral Med Oral Pathol 44:54-57.
177. Sist T, Wong C (2000). Difficult problems and their solutions in patients with cancer pain of the head and neck areas. Curr Rev Pain 4:206-214.
178. Slatkin NE, Rhiner M (2003). Topical ketamine in the treatment of mucositis pain. Pain Med 4:298-303.
179. Sloan PA, Moulin DE, Hays H (1998). A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 16:102-111.
180. Sonis ST (2004a). The pathobiology of mucositis. Nat Rev Cancer 4:277-284.
181. Sonis ST (2004b). Oral mucositis in cancer therapy. J Support Oncol 2(6 Suppl 3):3-8.
182. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. (2001). Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201-2205.
183. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. (2004a). Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl): 1995-2025.
184. Sonis ST, O'Donnell KE, Popat R, Bragdon C, Phelan S, Cocks D, et al (2004b). The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol 40:170-176.
185. Stiff P (2001). Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27(Suppl 2):S3-S11.
186. Syrjala KL, Chapko ME (1995). Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 61:69-79.
187. Syrjala KL, Donaldson GW, Davis MW, Kippes ME, Carr JE (1995). Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 63:189-198.
188. Taylor JC, Terrell JE, Ronis DL, Fowler KE, Bishop C, Lambert MT, et al. (2004). Disability in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130:764-769.
189. Teravainen H, Larsen A (1977). Some features of the neuromuscular complications of pulmonary carcinoma. Ann Neural 2:495-502.
190. Terrell JE, Nanavati K, Esclamado RM, Bradford CR, Wolf GT (1999). Health impact of head and neck cancer. Otolaryngol Head Neck Surg 120:852-859.
191. Terrell JE, Welsh DE, Bradford CR, Chepeha DB, Esclamado RM, Hogikyan ND, et al. (2000). Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope 110:620-626.
192. Thomason TE, McCune JS, Bernard SA, Winer EP, Tremont S, Lindley CM (1998). Cancer pain survey: patient-centered issues in control. J Pain Symptom Manage 15:275-284.
193. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. (2003). Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253-262.
194. Turgman J, Braham J, Modan B, Goldhammer Y (1978). Neurological complications in patients with malignant tumors of the nasopharynx. Eur Neuroin 17:149-154.
195. Turk DC (1999). The role of psychological factors in chronic pain. Acta Anaesthesiol Scand 43:885-888.
196. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987). A validation study of the WHO method for cancer pain relief. Cancer 59:850-856.
197. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ (1993). Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119:121-126.
198. Wang CJ, Howng SL (2001). Trigeminal neuralgia caused by nasopharyngeal carcinoma with skull base invasion - a case report. Kaohsiung J Med Sci 17:630-632.
199. Whelan HT, Smits RL Jr, Buchman EV, Whelan NT, Turner SG, Margolis DA, et al. (2001). Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg 19:305-314.
200. Witt C, Borges AC, Klein K, Neumann HJ (1997). Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients. J Oral Maxillofac Surg 55:450-453; discussion, 454-455.
201. Woo SB, Sonis ST, Monopoli MM, Sonis AL (1993). A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72:1612-1617.
202. Woo SB, Lee SJ, Schubert MM (1997). Graft-vs.-host disease. Crit Rev Oral Biol Med 8:201-216.
203. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA (1995). Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63:65-76.